Previous 10 | Next 10 |
home / stock / bayzf / bayzf news
The FDA has approved Bayer's ([[BAYZF]] -2.3%) supplemental marketing application allowing to add overall survival ((OS)) and other secondary endpoint data from Phase 3 ARAMIS trial to the prescribing information for its cancer treatment Nubeqa (darolutamide).In the trial, Nubeqa si...
This article initiates coverage of Bayer Aktiengesellschaft often called Bayer AG or just Bayer. Bayer has significant short-term headwinds which have depressed the stock price. It has high levels of debt and continues to have litigation pressures that will likely cost more than &...
In view of the overheated markets, it is worthwhile to take a look at the not so well-trodden paths. However, investors are facing a dilemma. There are a lot of great companies, but only a small number of good investments. In this article, I will name a few European companies that...
Veracyte (VCYT) is up +16.8% after announcing a collaboration with Bayer (BAYZF) to advance its Afirma Xpression Atlas for targeted therapies in patients with advanced or metastatic thyroid cancer.Regardless of the results and the treatment decision, Bayer will provide Afirma X...
Wuxi Biologics (WXXWY) is acquiring a drug substance facility from Bayer (BAYZF) to ramp up its global supply network of COVID-19 vaccines and other biologics.As part of the agreement, the two companies also plan to enter a long-term sublease agreement and a transition service contr...
November was characterized by a contested U.S. Presidential Election and a series of surprisingly positive and encouraging COVID-19 vaccine news. I am continuing my monthly investment plans and suspiciously follow the massive rally in technology stocks as well as the vaccine-driven re...
Project delays and slower than anticipated growth contradicts CLXT's business model that claim a speedy development cycle using novel gene-editing technologies. After unprofitable commercialization of the high oleic soybean oil, CLXT is shifting strategy to focus solely on seed produc...
Bayer (BAYZF), Atara Biotherapeutics (ATRA) have entered into an exclusive worldwide license agreement, for mesothelin-directed CAR T-cell therapies for the treatment of solid tumors.The agreement includes ATA3271, an allogeneic T-cell immunotherapy, and an autologous version, ATA2271, for hi...
The time has come once again to look at what sort of companies you'll want to be buying, this time as we move into December 2020. Rather than offering some sort of collective "list" that could potentially be hard to offer a clear overview, I go sector by sector and present 1-2 alterna...
Sigilon Therapeutics has filed proposed terms for its $101 million U.S. IPO. The firm is advancing programs to treat blood, lysosomal storage and other diseases. SGTX has produced a positive initial result with its first trial patient, has a strong collaboration relationship with ...
News, Short Squeeze, Breakout and More Instantly...
Bayer AG Registered Shares Company Name:
BAYZF Stock Symbol:
OTCMKTS Market:
NORTHAMPTON, MA / ACCESSWIRE / August 29, 2023 / Bayer - As climate change quickens, societal expectations increase and the threat of resistance grows, new crop protection solutions are imperative. Advances in the life sciences and data-driven technologies hold the key to expanding our pipeline ...
Monsanto Must Face Georgia State Jurors in Lawsuit Over Cancer-Causing Roundup Herbicide PR Newswire 11th Circuit opinion finds chemical giant subject to state's warning label laws Nachawati Law Group trial lawyers gearing up for next Roundup cancer trial in Au...
Bayer Runs Out of Appeals at US Supreme Court as Thousands of Cancer Lawsuits Await over Roundup Herbicide PR Newswire Fears Nachawati trial lawyers gearing up for next Roundup cancer trial in August WASHINGTON , June 22, 2022 /PRNewswire/ -- Baye...